Immediate Impact
2 from Science/Nature 59 standout
Citing Papers
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Segmental duplications and their variation in a complete human genome
2022 StandoutScience
Works of Ann Allen being referenced
Safety, tolerability, pharmacokinetics, and pharmacodynamics of vilanterol, a novel inhaled long‐acting β‐agonist, in children aged 5–11 years with persistent asthma: A randomized trial
2013
The relationship between paroxetine and the sparteine oxidation polymorphism
1992
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ann Allen | 348 | 368 | 233 | 40 | 836 | |
| Samer Mouksassi | 112 | 87 | 203 | 37 | 941 | |
| Partha Nandy | 128 | 111 | 206 | 45 | 923 | |
| Keita Hirai | 201 | 190 | 110 | 43 | 656 | |
| L Dettli | 68 | 114 | 276 | 51 | 866 | |
| J. P. Fillastre | 71 | 113 | 244 | 56 | 743 | |
| A. J. McLean | 66 | 110 | 142 | 44 | 903 | |
| A. Grahnén | 137 | 133 | 163 | 38 | 720 | |
| Alan K. Kamada | 509 | 378 | 77 | 26 | 862 | |
| Lawrence S. Olanoff | 71 | 93 | 137 | 27 | 802 | |
| Ali Beytur | 84 | 100 | 101 | 46 | 739 |
All Works
Loading papers...